Table 3.
Correlation between clinical variables and central sleep apnea
| Univariate logistic regression | Multivariate logistic regression | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p value | OR | 95% CI | p value | |
| Age (per 10 years) | 1.063 | 0.978–1.156 | .148 | 1.235 | 1.118–1.363 | <.001 |
| Male | 1.805 | 1.324–2.460 | <.001 | 1.699 | 1.220–2.366 | .002 |
| BMI (per 5 kg/m2) | 0.916 | 0.799–1.051 | .212 | – | – | – |
| Coronary artery disease | 1.200 | 0.930–1.547 | .161 | – | – | – |
| Hypertension | 0.932 | 0.726–1.195 | .577 | – | – | – |
| Diabetes | 1.040 | 0.791–1.366 | .780 | – | – | – |
| Atrial fibrillation | 0.888 | 0.685–1.150 | .368 | – | – | – |
| Heart rate (per 10 bpm) | 1.166 | 1.083–1.255 | <.001 | 1.174 | 1.085–1.271 | <.001 |
| Hemoglobin | 1.002 | 0.996–1.007 | .539 | – | – | – |
| lnNT‐proBNP | 1.393 | 1.240–1.563 | <.001 | 1.234 | 1.089–1.398 | .001 |
| LVEF (per 5%) | 0.873 | 0.832–0.916 | <.001 | 0.882 | 0.835–0.932 | <.001 |
| Hypocapnia | 1.665 | 1.285–2.156 | <.001 | 1.455 | 1.105–1.915 | .007 |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; CI, confidence interval; LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide; OR, odds ratio.